Mesa Laboratories (MLAB) Current Deferred Revenue (2013 - 2025)

Mesa Laboratories (MLAB) has 13 years of Current Deferred Revenue data on file, last reported at $14.6 million in Q4 2025.

• Quarterly Current Deferred Revenue fell 1.03% year-over-year to $14.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.6 million (down 1.03% YoY) and the FY2025 annual result came in at $14.7 million, down 4.96% from the prior year.
• Current Deferred Revenue grew to $14.6 million in Q4 2025 per MLAB's latest filing, from $14.3 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $16.3 million in Q3 2022, with the low at $8.8 million in Q1 2021.
• Average Current Deferred Revenue over 5 years is $14.0 million, with a median of $14.6 million recorded in 2022.
• Year-over-year, Current Deferred Revenue jumped 80.59% in 2021 and fell 10.04% in 2023.
• Mesa Laboratories' Current Deferred Revenue stood at $13.8 million in 2021, then climbed by 5.62% to $14.6 million in 2022, then declined by 1.56% to $14.4 million in 2023, then grew by 2.46% to $14.7 million in 2024, then declined by 1.03% to $14.6 million in 2025.
• Business Quant data shows MLAB's Current Deferred Revenue at $14.6 million in Q4 2025, $14.3 million in Q3 2025, and $15.1 million in Q2 2025.